Ticker Details
ANI Pharmaceuticals, Inc. ANI Pharmaceuticals Inc is a specialty pharmaceutical company. The Company, together with its subsidiary is engaged in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals.
IPO Date:	July 18, 2013
Sector:	Healthcare
Industry:	Pharma
Market Cap:	$1.73B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.00 | 2.14%
Avg Daily Range (30 D):	$1.40 | 1.76%
Avg Daily Range (90 D):	$1.27 | 1.58%

Institutional Daily Volume
Avg Daily Volume:	.15M
Avg Daily Volume (30 D):	.25M
Avg Daily Volume (90 D):	.25M

Trade Size
Avg Trade Size (Sh.):	63
Avg Trade Size (Sh.) (30 D):	40
Avg Trade Size (Sh.) (90 D):	40

Institutional Trades
Total Institutional Trades:	2,692
Avg Institutional Trade:	$2.32M
Avg Institutional Trade (30 D):	$3.3M
Avg Institutional Trade (90 D):	$3.41M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.78M
Avg Closing Trade (30 D):	$3.92M
Avg Closing Trade (90 D):	$4.45M
Avg Closing Volume:	42.68K

News

Jul 24, 2026 @ 10:50 AM ANI Pharmaceuticals to Discuss Second Quarter 2026... Source: Na

Jul 13, 2026 @ 10:50 AM ANI Pharmaceuticals Announces Positive Six-Month T... Source: Ani Pharmaceuticals, Inc.

Jul 13, 2026 @ 12:20 AM ANI Pharmaceuticals' CFO Sold $285,000 in Stock Af... Source: Jonathan Ponciano

May 11, 2026 @ 9:09 PM Global Alpha Dumps 229,000 Ani Pharmaceuticals (AN... Source: Cory Renauer

Mar 27, 2026 @ 10:30 PM ANI Pharma Insider Sells 4,772 Shares as Revenue H... Source: Jonathan Ponciano

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$4.83	$1.09	$1.31
Diluted EPS	$4.62	$1.05	$1.28
Revenue	$978.38M	$266.04M	$237.46M
Gross Profit
Net Income / Loss	$108.31M	$24.71M	$29.49M
Operating Income / Loss	$150.36M	$40.46M	$38.89M
Cost of Revenue
Net Cash Flow	$142.41M	$49.04M	$25.59M
PE Ratio

Splits
Jul 18, 2013	1:6
Jun 04, 2012	1:6
Jun 03, 2002	1:10